MYGN
Myriad Genetics Inc.
$7.84
+$0.33(+4.47%)
50
Overall
--
Value
58
Tech
42
Quality
Market Cap
$700.63M
Volume
577.05K
52W Range
$3.76 - $25.25
Target Price
$7.50
EPS Estimates Overview
| Current Quarter | $-0.11 | Next Quarter | $-0.09 |
| Current Year | $-0.4 | Next Year | $-0.28 |
| QoQ Growth | +18.2% | YoY Growth | +30.0% |
| 3Y EPS CAGR | -59.1% | Target Price | $7.50 |
| Consensus | Buy | Upside | -4.3% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MYGN | $7.84 | +4.5% | 577.05K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |